Market Overview:
The global oncology nutrition market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market is segmented by type, application, and region. The type segment includes head and neck cancers, stomach and gastrointestinal cancers, liver cancer, pancreatic cancer, esophageal cancer, lung cancer breast cancer blood cancer other cancers. The application segment includes clinic hospitals others. Region wise the market is divided into North America Latin America Europe Asia Pacific Middle East & Africa (MEA).
Product Definition:
Oncology nutrition is the study and practice of providing nutritional support to patients with cancer. Oncology nutrition is important because it can help improve a patient's quality of life by reducing symptoms, improving appetite, and preventing weight loss.
Head and Neck Cancers:
The global head and neck cancer statistics, prevalence, diagnosis & treatment information resource center is a comprehensive collection of data and research related to Head and Neck Cancer (HNC) including oral cavity, oropharynx, larynx, hypopharynx as well as the cervical region. The information was extracted from several sources such as government reports & databases (OCGBI), cancer statistics reviews (CSR), internet sources; newspapers etc.
Stomach and Gastrointestinal Cancers:
Stomach and gastrointestinal cancers and it's usage in oncology nutrition market is a group of diseases that begin when the cells that make up the stomach lining (gastrointestinal tract) grow out of control. The most common types are adenocarcinoma, carcinoid tumor, squamous cell carcinoma, mucinous cell carcinoma, and intestinal stromal tumor.
Application Insights:
The others cancer segment held the largest share of the global oncology nutrition market in 2017. This is owing to an increase in incidence of other cancers such as kidney, thyroid, and bone metastasis that require nutritional support. According to a study published by NCBI in 2018, it was estimated that around 15% of patients suffering from malignant tumors have inadequate nutrient intake due to which they become susceptible to secondary complications including death. Thus there is a high demand for oncology nutrition supplements and foods among patients diagnosed with other cancers who require nutritional support throughout their treatment course.
Nutraceutical companies are developing innovative products such as combination therapy tablets or capsules containing antineoplastic agents along with vitamins and minerals that help improve overall survival rates among cancer patients by reducing mortality rates caused due to malnutrition or under-nutrition.
Regional Analysis:
North America dominated the global oncology nutrition market in 2017. This can be attributed to the presence of key players, such as Abbott and Nestl©, which are engaged in extensive R&D for development of nutritional products for cancer patients. Moreover, increasing government initiatives and awareness about advanced therapies are also contributing towards growth of this regional market. For instance, The Cancer Genome Atlas (TCGA) program initiated by U.S National Cancer Institute (NCI) has developed a number of nutritional supplements that contain high amounts of nutrients such as B-vitamins and folate to treat different types of cancers including lung cancer, breast cancer & others).
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for oncology nutrition market. According to World Health Organization (WHO), the number of new cases of cancer is expected to rise from 14 million in 2012 to 22 million by 2030. This will create a huge demand for oncology nutrition products and services, which will drive the growth of oncology nutrition market.
- Rising awareness about benefits of oncology nutrition: There is a growing awareness among people about the benefits of oncology nutrition products and services. This is driving people towards using these products and services, which is propelling the growth of this market.
- Technological advancements in Oncology Nutrition: The technological advancements in Oncology Nutrition are helping medical professionals to provide better treatment options to patients suffering from cancer, thereby driving the growth prospects for this market during forecast period 2016-2022 . For instance, In January 2017, Nestlé Health Science announced that it has received US FDA approval for its investigational product candidate Nutritional Support System (NSS) designed specifically for patients with head and neck cancers receiving radiation therapy (RT). Such technological advancements are aiding in boosting adoption rateofonoclogynutritionproductsandservicesamongpatientsandhealthcareprofessionalsalikeandwillcontributetothegrowthofthemarketinthefutureperiods .
Scope Of The Report
Report Attributes
Report Details
Report Title
Oncology Nutrition Market Research Report
By Type
Head and Neck Cancers, Stomach and Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Esophageal Cancer, Lung Cancer, Breast Cancer, Blood Cancer, Other Cancers
By Application
Clinic, Hospitals, Others
By Companies
Abbott Laboratories, Nestle, Danone, Fresenius Kabi, B. Braun
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
186
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global Oncology Nutrition Market Report Segments:
The global Oncology Nutrition market is segmented on the basis of:
Types
Head and Neck Cancers, Stomach and Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Esophageal Cancer, Lung Cancer, Breast Cancer, Blood Cancer, Other Cancers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinic, Hospitals, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Nestle
- Danone
- Fresenius Kabi
- B. Braun
Highlights of The Oncology Nutrition Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Head and Neck Cancers
- Stomach and Gastrointestinal Cancers
- Liver Cancer
- Pancreatic Cancer
- Esophageal Cancer
- Lung Cancer
- Breast Cancer
- Blood Cancer
- Other Cancers
- By Application:
- Clinic
- Hospitals
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oncology Nutrition Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oncology nutrition is the study of how cancer patients and their caregivers can optimize their diets to support optimal health and well-being. Oncology nutritionists help patients with cancer manage their symptoms, improve quality of life, and extend survival.
Some of the key players operating in the oncology nutrition market are Abbott Laboratories, Nestle, Danone, Fresenius Kabi, B. Braun.
The oncology nutrition market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oncology Nutrition Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oncology Nutrition Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oncology Nutrition Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oncology Nutrition Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oncology Nutrition Market Size & Forecast, 2018-2028
4.5.1 Oncology Nutrition Market Size and Y-o-Y Growth
4.5.2 Oncology Nutrition Market Absolute $ Opportunity
Chapter 5 Global Oncology Nutrition Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Oncology Nutrition Market Size Forecast by Type
5.2.1 Head and Neck Cancers
5.2.2 Stomach and Gastrointestinal Cancers
5.2.3 Liver Cancer
5.2.4 Pancreatic Cancer
5.2.5 Esophageal Cancer
5.2.6 Lung Cancer
5.2.7 Breast Cancer
5.2.8 Blood Cancer
5.2.9 Other Cancers
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Oncology Nutrition Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Oncology Nutrition Market Size Forecast by Applications
6.2.1 Clinic
6.2.2 Hospitals
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oncology Nutrition Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oncology Nutrition Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Oncology Nutrition Analysis and Forecast
9.1 Introduction
9.2 North America Oncology Nutrition Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Oncology Nutrition Market Size Forecast by Type
9.6.1 Head and Neck Cancers
9.6.2 Stomach and Gastrointestinal Cancers
9.6.3 Liver Cancer
9.6.4 Pancreatic Cancer
9.6.5 Esophageal Cancer
9.6.6 Lung Cancer
9.6.7 Breast Cancer
9.6.8 Blood Cancer
9.6.9 Other Cancers
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Oncology Nutrition Market Size Forecast by Applications
9.10.1 Clinic
9.10.2 Hospitals
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Oncology Nutrition Analysis and Forecast
10.1 Introduction
10.2 Europe Oncology Nutrition Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Oncology Nutrition Market Size Forecast by Type
10.6.1 Head and Neck Cancers
10.6.2 Stomach and Gastrointestinal Cancers
10.6.3 Liver Cancer
10.6.4 Pancreatic Cancer
10.6.5 Esophageal Cancer
10.6.6 Lung Cancer
10.6.7 Breast Cancer
10.6.8 Blood Cancer
10.6.9 Other Cancers
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Oncology Nutrition Market Size Forecast by Applications
10.10.1 Clinic
10.10.2 Hospitals
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Oncology Nutrition Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Oncology Nutrition Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Oncology Nutrition Market Size Forecast by Type
11.6.1 Head and Neck Cancers
11.6.2 Stomach and Gastrointestinal Cancers
11.6.3 Liver Cancer
11.6.4 Pancreatic Cancer
11.6.5 Esophageal Cancer
11.6.6 Lung Cancer
11.6.7 Breast Cancer
11.6.8 Blood Cancer
11.6.9 Other Cancers
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Oncology Nutrition Market Size Forecast by Applications
11.10.1 Clinic
11.10.2 Hospitals
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Oncology Nutrition Analysis and Forecast
12.1 Introduction
12.2 Latin America Oncology Nutrition Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Oncology Nutrition Market Size Forecast by Type
12.6.1 Head and Neck Cancers
12.6.2 Stomach and Gastrointestinal Cancers
12.6.3 Liver Cancer
12.6.4 Pancreatic Cancer
12.6.5 Esophageal Cancer
12.6.6 Lung Cancer
12.6.7 Breast Cancer
12.6.8 Blood Cancer
12.6.9 Other Cancers
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Oncology Nutrition Market Size Forecast by Applications
12.10.1 Clinic
12.10.2 Hospitals
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Oncology Nutrition Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Oncology Nutrition Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Oncology Nutrition Market Size Forecast by Type
13.6.1 Head and Neck Cancers
13.6.2 Stomach and Gastrointestinal Cancers
13.6.3 Liver Cancer
13.6.4 Pancreatic Cancer
13.6.5 Esophageal Cancer
13.6.6 Lung Cancer
13.6.7 Breast Cancer
13.6.8 Blood Cancer
13.6.9 Other Cancers
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Oncology Nutrition Market Size Forecast by Applications
13.10.1 Clinic
13.10.2 Hospitals
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oncology Nutrition Market: Competitive Dashboard
14.2 Global Oncology Nutrition Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Nestle
14.3.3 Danone
14.3.4 Fresenius Kabi
14.3.5 B. Braun
